1. Schering Corporation (24 from 1,829 patents)

2. Scios Inc. (21 from 82 patents)

3. Medivation Technologies, Inc. (8 from 63 patents)

4. Sphaera Pharma Pvt. Ltd. (5 from 5 patents)

5. Sphaera Pharma Pte. Ltd. (5 from 5 patents)

6. Epirium Bio Inc. (4 from 5 patents)

7. Bristol-myers Squibb Compnay (3 from 3,669 patents)

8. Unicycive Therapeutics, Inc. (3 from 4 patents)

9. Inhibikase Therapeutics, Inc. (2 from 9 patents)

10. Cardero Therapeutics, Inc. (2 from 3 patents)

11. Drug Discovery Research Centre (2 from 2 patents)

12. University of Colorado (1 from 1,360 patents)

13. Schering-plough Corporation (1 from 28 patents)

14. Ixchel Pharma, Inc. (1 from 1 patent)

15. Colorado Research Partners. LLC (1 from 1 patent)

1. 12396989 - Nicorandil derivatives

2. 12377082 - Nicorandil derivatives

3. 12036211 - Nicorandil derivatives

4. 11542298 - Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof

5. 11273144 - Compounds and compositions for the treatment of muscular disorders and bone disorders

6. 11142501 - Prodrugs of monomethyl fumarate

7. 11083720 - Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases

8. 10898465 - Utility of (+) epicatechin and their analogs

9. 10752589 - Trigonelline based compounds

10. 10618933 - Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof

11. 10207993 - Compounds as anti-tubercular agents

12. 10100012 - Compounds as anti-tubercular agents

13. 9975869 - Analogues of epicatechin and related polyphenols

14. 9907796 - Methods of treating tumoral diseases, or bacterial or viral infections

15. 9901564 - Compounds and compositions for the treatment of muscular disorders